You are here: Industry Insights > oncology

News List

MAIA Biotechnology Announces Additions to Executive Team and Board of Directors firstwordpharma
August 05, 2021
MAIA Biotechnology, Inc., today announced that it has appointed Mihail Obrocea, M.D., as Chief Medical Officer and Head of Development, and Charlotte Tsou as an independent member of its board of directors.
CytRx Announces Director Election Results from 2021 Annual Meeting of Stockholders firstwordpharma
July 30, 2021
CytRx Corporation (OTCQB: CYTR) today announced that based on results from its 2021 Annual Meeting of Stockholders (the "Annual Meeting"), both of the Company's Class III director candidates have been elected to the Board of Directors (the "Board").
Erasca Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares firstwordpharma
July 21, 2021
Erasca, Inc. (Nasdaq: ERAS) today announced the closing of its initial public offering of 21,562,500 shares of common stock, which includes the exercise in full by the underwriters of their option to purchase 2,812,500 additional shares.
Arcus CMO moving to Gilead to head clinical oncology research firstwordpharma
July 20, 2021
Arcus Biosciences disclosed in a US Securities and Exchange Commission filing Monday that chief medical officer Bill Grossman will transition out of his role at the company to take up the post of senior vice president of oncology clinical research.
2021 is a key year for personalised neoantigen immuno-oncology therapeutics: GlobalData expresspharma
July 15, 2021
The four molecules expected to launch first, autogene cevumeran, GRANITE-001, ATL001, and Genocea Biosciences’ GEN-009 have combined peak forecast sales of over $1 billion by 2027.
BioMed X and Merck KGaA, Darmstadt, Germany Launch New Research Program in Oncology b3cnewswire
July 06, 2021
BioMed X, a leading independent research institute, announced today the start of its eighth joint research program with Merck KGaA, Darmstadt, Germany.
Patient access to gene therapies for cancer likely to increase in the next decade: GlobalData expresspharma
June 29, 2021
These therapies are expected to eliminate the need for further treatments and reduce the cost of disease management.
Heat Biologics Announces Expansion of R&D and Pre-Clinical Capacity at Corporate Headquarters americanpharmaceuticalreview
June 25, 2021
Heat Biologics, Inc. announced the expansion of its research and development facilities in Morrisville, North Carolina.
Global oncology Phase II clinical trials get disrupted by COVID-19: GlobalData expresspharma
June 15, 2021
Slow enrollment was the top reason, followed by enrollment suspension and lastly delayed initiation.
Gossamer Bio Appoints Sandra Milligan to its Board of Directors firstwordpharma
June 15, 2021
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics today announced the appointment of Sandra Milligan, M.D., J.D., to its Board of Directors.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page